These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36050862)
1. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365-72. Sun X; Wang Q; Shi Q Clin Chem Lab Med; 2022 Oct; 60(11):e243. PubMed ID: 36050862 [No Abstract] [Full Text] [Related]
2. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365-72. Smith TP; Fahie-Wilson MN Clin Chem Lab Med; 2022 Oct; 60(11):e244-e245. PubMed ID: 36052827 [No Abstract] [Full Text] [Related]
4. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin. McCudden CR; Sharpless JL; Grenache DG Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and reproductive manifestations of macroprolactinemia. Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265 [TBL] [Abstract][Full Text] [Related]
6. Macroprolactin: From laboratory to clinical practice. Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561 [TBL] [Abstract][Full Text] [Related]
7. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia]. Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444 [TBL] [Abstract][Full Text] [Related]
8. Serum prolactin and macroprolactin levels in diabetic nephropathy. Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335 [TBL] [Abstract][Full Text] [Related]
9. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study. Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188 [TBL] [Abstract][Full Text] [Related]
10. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report. Cattaneo FA; Fahie-Wilson MN J Neurosurg; 2001 Aug; 95(2):334-7. PubMed ID: 11780906 [TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia. Alfonso A; Rieniets KI; Vigersky RA Endocr Pract; 2006; 12(3):275-80. PubMed ID: 16772199 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey. Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438 [TBL] [Abstract][Full Text] [Related]
13. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Suliman AM; Smith TP; Gibney J; McKenna TJ Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin. Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894 [TBL] [Abstract][Full Text] [Related]
15. [Prolactin and the laboratory]. Veloza A; Prazeres S Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514 [TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study. Krysiak R; Szkróbka W; Okopień B Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509 [TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor relating to Clin Chem Lab Med 2018;56(7):1090-1099. Infantino M; Grossi V; Benucci M; Manfredi M Clin Chem Lab Med; 2019 Mar; 57(4):e45-e46. PubMed ID: 30138111 [No Abstract] [Full Text] [Related]
18. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Overgaard M; Pedersen SM Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625 [TBL] [Abstract][Full Text] [Related]